Axsome Therapeutics (AXSM) Assets Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) Assets Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 12.25 Bn | 11.94 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.40% |
| Dec 31, 2025 | 27.67% |
| Sep 30, 2025 | 25.45% |
| Jun 30, 2025 | 52.45% |
| Mar 31, 2025 | 88.87% |
| Dec 31, 2024 | 86.40% |
| Sep 30, 2024 | 68.87% |
| Jun 30, 2024 | 56.41% |
| Mar 31, 2024 | 48.42% |
| Dec 31, 2023 | 46.75% |
| Sep 30, 2023 | 43.43% |
| Jun 30, 2023 | 47.40% |
| Mar 31, 2023 | 25.31% |
| Dec 31, 2022 | 14.55% |
| Sep 30, 2022 | 96.85% |
| Jun 30, 2022 | 48.82% |
| Mar 31, 2022 | 26.35% |
| Dec 31, 2021 | 78.72% |
| Sep 30, 2021 | 93.37% |
| Jun 30, 2021 | 87.52% |